Genvor is at the forefront of agricultural innovation, leveraging AI technology to develop targeted peptide solutions that address critical needs in agriculture. Their platform enables sustainable, residue-free crop protection, enhancing productivity and regulatory compliance. Genvor's scalable and adaptable peptide platform supports various application methods and integrates seamlessly with existing agricultural practices, offering solutions for disease control, seed traits, and bio-stimulants. Backed by years of research and collaboration with the USDA, Genvor is committed to transforming agriculture with flexible, scalable delivery systems.
We're tracking Genvor's market expansion
How Genvor's international expansion compares to its competitors
GenvorYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 GenvorYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Genvor appoints Dr. George Stavrides as EVP of Business Development & Commercialization, bringing 15+ years of experience from Syngenta to accelerate partnerships and market expansion.
Genvor (OTCQB: GNVR), an AI-driven biotech company developing peptides for agriculture and human health, will present at the Centri Capital Conference on April 14 at Nasdaq in NYC.
Be the first to find verified contacts at Genvor
Quick answers about Genvor's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
